Cited by 2,029RNA Research and SplicingAcute Myeloid Leukemia ResearchGenomics and Rare Diseases

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Frequent pathway mutations of splicing machinery in myelodysplasia

Yoshida, Kenichi, Sanada, Masashi, Shiraishi, Yuichi, Nowak, Daniel, Nagata, Yasunobu, Yamamoto, Ryo, Sato, Yusuke, Sato-Otsubo, Aiko, Kon, Ayana, Nagasaki, Masao, Chalkidis, George, Suzuki, Yutaka, Shiosaka, Masashi, Kawahata, Ryoichiro, Yamaguchi, Tomoyuki, Otsu, Makoto, Obara, Naoshi, Sakata-Yanagimoto, Mamiko, Ishiyama, Ken, Mori, Hiraku, Nolte, Florian, Hofmann, Wolf-Karsten, Miyawaki, Shuichi, Sugano, Sumio, Haferlach, Claudia, Koeffler, H. Phillip, Shih, Lee-Yung, Haferlach, Torsten, Chiba, Shigeru, Nakauchi, Hiromitsu, Miyano, Satoru, Ogawa, Seishi·2011·Nature

DOI 10.1038/nature10496

Open this paper in CoChat — free account

Abstract

Myelodysplastic syndromes and related disorders (myelodysplasia) are a heterogeneous group of myeloid neoplasms showing deregulated blood cell production with evidence of myeloid dysplasia and a predisposition to acute myeloid leukaemia, whose pathogenesis is only incompletely understood. Here we report whole-exome sequencing of 29 myelodysplasia specimens, which unexpectedly revealed novel pathway mutations involving multiple components of the RNA splicing machinery, including U2AF35, ZRSR2, SRSF2 and SF3B1. In a large series analysis, these splicing pathway mutations were frequent (∼45 to ∼85%) in, and highly specific to, myeloid neoplasms showing features of myelodysplasia. Conspicuously, most of the mutations, which occurred in a mutually exclusive manner, affected genes involved in the 3'-splice site recognition during pre-mRNA processing, inducing abnormal RNA splicing and compromised haematopoiesis. Our results provide the first evidence indicating that genetic alterations of the major splicing components could be involved in human pathogenesis, also implicating a novel therapeutic possibility for myelodysplasia.

Integrity signals

Registry

Crossref · 10.1038/nature10496

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
Next-generation DNA sequencing
Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,529
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,457
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434

Flagged first, then by citations

Show all 37 references

Sorted by citations

Items 401–500 of 1,002

Turning the tide in myelodysplastic/myeloproliferative neoplasms
Deininger, M. W., Tyner, J. W., & Solary, É. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.40 · Cited by 88
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer
Matsuda, T., Leisegang, M., Park, J.-H., Ren, L., Kato, T., Ikeda, Y., Harada, M., Kiyotani, K., Lengyel, E. R., Fleming, G. F., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0142 · Cited by 83
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Font, P., Loscertales, J., Soto, C., Ricard, P., Muñoz‐Novas, C., Martín‐Clavero, E., López-Rubio, M., Garcia-Alonso, L., Callejas, M., Bermejo, A., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2252-4 · Cited by 81
SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment
Mian, S. A., Rouault‐Pierre, K., Smith, A., Seidl, T., Pizzitola, I., Kizilors, A., Kulasekararaj, A. G., Bonnet, D. A., & Mufti, G. J. (2015) · Nature Communications · doi:10.1038/ncomms10004 · Cited by 87
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
Jiménez‐Vacas, J. M., Herrero‐Aguayo, V., Gómez‐Gómez, E., León‐González, A. J., Sáez-Martínez, P., Alors‐Pérez, E., Fuentes-Fayos, A. C., Martínez-López, A., Sánchez‐Sánchez, R., González-Serrano, T., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.07.001 · Cited by 82
Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blasts
Patnaik, M. M., Hanson, C. A., Sulai, N. H., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Lasho, T. L., & Tefferi, A. (2012) · Blood · doi:10.1182/blood-2012-03-415356 · Cited by 80
Splicing heterogeneity: separating signal from noise
Wan, Y., & Larson, D. R. (2018) · Genome biology · doi:10.1186/s13059-018-1467-4 · Cited by 82
Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
Takayama, K. (2019) · Biomolecules · doi:10.3390/biom9040131 · Cited by 84
Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
Jamal, M., Song, T., Chen, B., Faisal, M., Hong, Z., Xie, T., Wu, Y., Pan, S., Yin, Q., Shao, L., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01108 · Cited by 80
Structural and functional modularity of the U2 snRNP in pre-mRNA splicing
van der Feltz, C. L., & Hoskins, A. A. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1691497 · Cited by 81
Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
Hou, H., & Tien, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00674-7 · Cited by 86
Molecular impact of mutations in RNA splicing factors in cancer
Zhang, Q., Ai, Y., & Abdel-Wahab, O. I. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.07.019 · Cited by 84
Aberrant 3′ oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia
Hilcenko, C., Simpson, P. J., Finch, A. J., Bowler, F. R., Churcher, M. J., Jin, L., Packman, L. C., Shlien, A., Campbell, P., Kirwan, M., et al. (2012) · Blood · doi:10.1182/blood-2012-10-461491 · Cited by 81
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
Leisegang, M., Engels, B., Schreiber, K., Yew, P. Y., Kiyotani, K., Idel, C., Arina, A., Duraiswamy, J., Weichselbaum, R. R., Uckert, W., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2361 · Cited by 83
Application of an NGS ‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera
Delic, S., Rose, D., Kern, W., Nadarajah, N., Haferlach, C., Haferlach, T., & Meggendorfer, M. (2016) · British Journal of Haematology · doi:10.1111/bjh.14269 · Cited by 79
Self-citation
U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Qian, J., Yao, D., Lin, J., Qian, W., Wang, C.-Z., Chai, H., Yang, J. C., Li, Y., Deng, Z., Ma, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045760 · Cited by 78
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia
Zhou, Y., Han, C., Wang, E., Lorch, A. H., Serafin, V., Cho, B.-K., Gutierrez-Diaz, B. T., Calvo, J., Fang, C., Khodadadi‐Jamayran, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1436 · Cited by 80
Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies
Biancon, G., Joshi, P. M., Zimmer, J. T., Hunck, T., Gao, Y., Lessard, M. D., Courchaine, E. M., Barentine, A. E. S., Machyna, M., Botti, V., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.025 · Cited by 78
Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities
Tétreault, M., Bareke, E., Nadaf, J., Alirezaie, N., & Majewski, J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1039516 · Cited by 81
Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas
Zhao, Q., Caballero, O. L., Davis, I. D., Jonasch, E., Tamboli, P., Yung, W. K. A., Weinstein, J. N., Strausberg, R. L., & Yao, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3708 · Cited by 82
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
Feenstra, J. D. M., Puda, A., Malcovati, L., Berg, T., Hofbauer, M., Stukalov, A., Klampfl, T., Harutyunyan, A. S., Gisslinger, H., Gisslinger, B., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23309 · Cited by 84
A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies
Inoue, D., Fujino, T., Sheridan, P. J., Zhang, Y., Nagase, R., Horikawa, S., Li, Z., Matsui, H., Kanai, A., Saika, M., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0083-3 · Cited by 78
Self-citation
Diagnostic Applications of High-Throughput DNA Sequencing
Boyd, S. D. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164026 · Cited by 78
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome
Mian, S. A., Smith, A., Kulasekararaj, A. G., Kizilors, A., Mohamedali, A. M., Lea, N. C., Mitsopoulos, C., Ford, K., Nasser, E. E., Seidl, T., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.075325 · Cited by 77
SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicingPreprint
Tang, Q., Rodriguez-Santiago, S., Wang, J., Pu, J., Yuste, A., Gupta, V., Moldón, A., Xu, Y., & Query, C. C. (2016) · Genes & Development · doi:10.1101/gad.291872.116 · Cited by 80
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes
Hunter, A. M., Komrokji, R. S., Yun, S., Al Ali, N., Chan, O., Song, J., Hussaini, M., Talati, C., Sweet, K. L., Lancet, J. E., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003508 · Cited by 76
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
Bamopoulos, S. A., Batcha, A. M. N., Jurinović, V., Rothenberg‐Thurley, M., Janke, H., Ksienzyk, B., Philippou‐Massier, J., Graf, A., Krebs, S., Blum, H., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0839-4 · Cited by 77
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
Choudhary, G. S., Pellagatti, A., Agianian, B., Smith, M. A., Bhagat, T. D., Gordon-Mitchell, S., Sahu, S., Pandey, S., Shah, N. N., Aluri, S., et al. (2022) · eLife · doi:10.7554/elife.78136 · Cited by 76
Coherence between Cellular Responses and in Vitro Splicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs
Effenberger, K. A., Anderson, D. D., Bray, W. M., Prichard, B. E., Ma, N., Adams, M. S., Ghosh, A. K., & Jurica, M. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515536 · Cited by 80
U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype
Tefferi, A., Finke, C. M., Lasho, T. L., Wassie, E. A., Knudson, R. A., Ketterling, R. P., Hanson, C. A., & Pardanani, A. D. (2013) · Leukemia · doi:10.1038/leu.2013.286 · Cited by 76
Genetic and epigenetic alterations of myeloproliferative disorders
Feenstra, J. D. M., & Královics, R. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1235-2 · Cited by 81
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
Aird, D. R., Teng, T., Huang, C. L., Pazolli, E., Banka, D., Cheung-Ong, K., Eifert, C., Furman, C., Wu, Z. J., Seiler, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08150-5 · Cited by 78
Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia
Zhu, C., Lian, Y., Wang, C., Wu, P., Li, X., Gao, Y., Fan, S., Ai, L., Fang, L., Pan, H., et al. (2021) · Blood · doi:10.1182/blood.2020008966 · Cited by 79
SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Blanco, T. M., Dimitriou, M., Woll, P. S., Karimi, M., Elvarsdóttir, E. M., Conte, S., Tobiasson, M., Jansson, M., Douagi, I., Moarii, M., et al. (2017) · Blood · doi:10.1182/blood-2017-03-776070 · Cited by 80
Targeting splicing abnormalities in cancer
Agrawal, A. A., Yu, L., Smith, P. G., & Buonamici, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.010 · Cited by 79
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
Paolella, B. R., Gibson, W. J., Urbanski, L. M., Alberta, J. A., Zack, T. I., Bandopadhayay, P., Nichols, C. A., Agarwalla, P. K., Brown, M. S., Lamothe, R. C., et al. (2017) · eLife · doi:10.7554/elife.23268 · Cited by 76
The genetic and molecular pathogenesis of myelodysplastic syndromes
Shallis, R. M., Ahmad, R., & Zeidan, A. M. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13092 · Cited by 76
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
Visconte, V., Nakashima, M. O., & Rogers, H. J. (2019) · Cancers · doi:10.3390/cancers11121844 · Cited by 77
A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development
Cesana, M., Guo, M. H., Cacchiarelli, D., Wahlster, L., Barragan, J., Doulatov, S. R., Vo, L. T., Salvatori, B., Trapnell, C., Clement, K., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.03.012 · Cited by 74
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
Jeromin, S., Haferlach, T., Weißmann, S., Meggendorfer, M., Eder, C., Nadarajah, N., Alpermann, T., Kohlmann, A., Kern, W., Haferlach, C., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.119032 · Cited by 75
Self-citation
Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome
Kröger, N. M. (2012) · Blood · doi:10.1182/blood-2011-12-380162 · Cited by 75
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
Alessandrino, E. P., Porta, M. G. D., Malcovati, L., Jackson, C. H., Pascutto, C., Bacigalupo, A. P., Lint, M. T. V., Falda, M., Bernardi, M., Onida, F., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23458 · Cited by 73
An extended U2AF65–RNA-binding domain recognizes the 3′ splice site signal
Agrawal, A. A., Salsi, E., Chatrikhi, R., Henderson, S., Jenkins, J. L., Green, M. R., Ermolenko, D. N., & Kielkopf, C. L. (2016) · Nature Communications · doi:10.1038/ncomms10950 · Cited by 75
Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape
SILVA, P. B. E. D., Neumann, M., Schroeder, M. P., Vosberg, S., Schlee, C., Isaakidis, K., Ortiz-Tánchez, J., Fransecky, L. R., Hartung, T., Türkmen, S., et al. (2017) · Leukemia · doi:10.1038/leu.2017.109 · Cited by 72
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
Lu, Q., Zhang, X., Liang, T., & Bai, X. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00544-y · Cited by 71
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML
Hirabayashi, S., Flotho, C., Moetter, J., Heuser, M., Hasle, H., Gruhn, B., Klingebiel, T. E., Thol, F. R., Schlegelberger, B., Baumann, I., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395087 · Cited by 71
Self-citation
Recognition of the 3′ splice site RNA by the U2AF heterodimer involves a dynamic population shift
von Voithenberg, L. V., Sánchez‐Rico, C., Kang, H.-S., Madl, T., Zanier, K., Barth, A., Warner, L., Sattler, M., & Lamb, D. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605873113 · Cited by 76
A comprehensive characterization of cis -acting splicing-associated variants in human cancerPreprint
Shiraishi, Y., Kataoka, K., Chiba, K., Okada, A., Kogure, Y., Tanaka, H., Ogawa, S., & Miyano, S. (2018) · Genome Research · doi:10.1101/gr.231951.117 · Cited by 72
Self-citation
Current and emerging strategies for management of myelodysplastic syndromes
Saygin, C., & Carraway, H. E. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100791 · Cited by 70
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
Wu, S., Tang, J., Lin, C., Kuo, Y., Li, L.-Y., Tseng, M., Huang, C., Lai, Y., Lee, F., Liu, M.-C., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23541 · Cited by 71
Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator
Liu, H., Lorenzini, P. A., Zhang, F., Xu, S., Wong, M. S. M., Zheng, J., & Roca, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky401 · Cited by 74
Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma
Kiyotani, K., Park, J.-H., Inoue, H., Husain, A. N., Olugbile, S. O., Zewde, M. G., Nakamura, Y., & Vigneswaran, W. T. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1278330 · Cited by 69
Single-cell analysis based dissection of clonality in myelofibrosis
Mylonas, E., Yoshida, K., Frick, M., Hoyer, K., Christen, F., Kaeda, J., Obenaus, M., Noerenberg, D., Hennch, C., Chan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13892-x · Cited by 72
Self-citation
Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation
Popli, P., Richters, M. M., Chadchan, S. B., Kim, T. H., Tycksen, E., Griffith, O. L., Thaker, P. H., Griffith, M., & Kommagani, R. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03055-y · Cited by 69
Splicing alterations in healthy aging and disease
Angarola, B. L., & Anczuków, O. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1643 · Cited by 73
Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors
Je, E. M., Yoo, N. J., Kim, Y. J., Kim, M., & Lee, S. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28011 · Cited by 73
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Gupte, A., Baker, E. K., Wan, S.-S., Stewart, E. A., Loh, A. H. P., Shelat, A. A., Gould, C. M., Chalk, A. M., Taylor, S., Lackovic, K., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3026 · Cited by 70
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
van de Loosdrecht, A. A., Ireland, R. M., Kern, W., Porta, M. G. D., Alhan, C., Balleisen, J. S., Bettelheim, P., Bowen, D., Burbury, K., Eidenschink, L., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.718341 · Cited by 71
Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
van der Wal, E., Bergsma, A. J., Pijnenburg, J. M., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.03.001 · Cited by 69
Defects in spliceosomal machinery: a new pathway of leukaemogenesis
Maciejewski, J. P., & Padgett, R. A. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09158.x · Cited by 72
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1
Fei, D. L., Zhen, T., Durham, B. H., Ferrarone, J. R., Zhang, T., Garrett, L. J., Yoshimi, A., Abdel-Wahab, O. I., Bradley, R. K., Liu, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812669115 · Cited by 72
Splicing and cancer: Challenges and opportunities
Coltri, P. P., dos Santos, M. G. P., & Silva, G. K. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1527 · Cited by 69
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
Dalton, W. B., Helmenstine, E., Walsh, N., Gondek, L. P., Kelkar, D. S., Read, A., Natrajan, R., Christenson, E. S., Román, B., Das, S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125022 · Cited by 70
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
Kirtonia, A., Pandya, G., Sethi, G., Pandey, A. K., Das, B. C., & Garg, M. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01944-5 · Cited by 68
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths
Cortés-López, M., Chamely, P., Hawkins, A. G., Stanley, R. F., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.012 · Cited by 69
Next generation sequencing reveals genetic landscape of hepatocellular carcinomas
Li, S., & Mao, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.09.027 · Cited by 69
Splicing in oncogenesis and tumor suppression
Kaida, D., Schneider‐Poetsch, T., & Yoshida, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02356.x · Cited by 71
Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors
Scott, L. M., & Rebel, V. I. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt257 · Cited by 68
Aberrant splicing and drug resistance in AML
de Necochea-Campion, R., Shouse, G. P., Zhou, Q., Mirshahidi, S., & Chen, C.-S. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0315-9 · Cited by 66
EZH2 in Myeloid Malignancies
Rinke, J., Chase, A., Cross, N. C. P., Hochhaus, A., & Ernst, T. (2020) · Cells · doi:10.3390/cells9071639 · Cited by 71
Single-Nucleotide Resolution Mapping of the Gossypium raimondii Transcriptome Reveals a New Mechanism for Alternative Splicing of Introns
Li, Q., Xiao, G., & Zhu, Y. (2014) · Molecular Plant · doi:10.1093/mp/sst175 · Cited by 66
Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
Landau, D. A., & Wu, C. J. (2013) · Genome Medicine · doi:10.1186/gm451 · Cited by 70
Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features
Ondrejka, S. L., Grzywacz, B. J., Bodo, J., Makishima, H., Polprasert, C., SAID, J. W., Przychodzen, B. P., Maciejewski, J. P., & Hsi, E. D. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000555 · Cited by 66
Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
Jenkins, J. L., & Kielkopf, C. L. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.03.001 · Cited by 67
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes
Li, B., Liu, J., Jia, Y., Wang, J., Xu, Z., Qin, T., Shi, Z., Song, Z., Peng, S., Huang, H., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22510 · Cited by 66
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
Nagata, Y., Makishima, H., Kerr, C. M., Przychodzen, B. P., Aly, M. M., Goyal, A., Awada, H. K., Asad, M., Kuzmanovic, T., Suzuki, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13001-y · Cited by 69
Self-citation
Next‐generation sequencing – feasibility and practicality in haematology
Kohlmann, A., Großmann, V., Nadarajah, N., & Haferlach, T. (2013) · British Journal of Haematology · doi:10.1111/bjh.12194 · Cited by 65
Self-citation
Whole‐exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia
Shiba, N., Yoshida, K., Shiraishi, Y., Okuno, Y., Yamato, G., Hara, Y., Nagata, Y., Chiba, K., Tanaka, H., Terui, K., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14247 · Cited by 67
Self-citation
Splicing in immune cells—mechanistic insights and emerging topics
Schaub, A., & Glasmacher, E. (2017) · International Immunology · doi:10.1093/intimm/dxx026 · Cited by 68
Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management
Patnaik, M. M., & Tefferi, A. (2016) · American Journal of Hematology · doi:10.1002/ajh.24396 · Cited by 64
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax
Lachowiez, C. A., Loghavi, S., Furudate, K., Bravo, G. M., Maiti, A., Kadia, T. M., Daver, N. G., Borthakur, G. M., Pemmaraju, N., Sasaki, K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004173 · Cited by 64
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease
Marabti, E. E., & Abdel-Wahab, O. I. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.04.005 · Cited by 66
Preleukemia: one name, many meanings
Koeffler, H. P., & Leong, G. X. Y. (2016) · Leukemia · doi:10.1038/leu.2016.364 · Cited by 67
Self-citation
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
Cortés-López, M., Schulz, L., Enculescu, M., Paret, C., Spiekermann, B., Quesnel-Vallières, M., Torres-Diz, M., Unic, S., Busch, A., Orekhova, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31818-y · Cited by 65
Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron
Visconte, V., Avishai, N., Mahfouz, R. Z., Tabarroki, A., Cowen, J., Sharghi-Moshtaghin, R., Hitomi, M., Rogers, H. J., Hasrouni, E., Phillips, J., et al. (2014) · Leukemia · doi:10.1038/leu.2014.170 · Cited by 64
Functional genomics identifies a requirement of pre‐mRNA splicing factors for sister chromatid cohesion
Sundaramoorthy, S., Vázquez‐Novelle, M. D., Lekomtsev, S., Howell, M. T., & Petronczki, M. P. (2014) · The EMBO Journal · doi:10.15252/embj.201488244 · Cited by 66
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes
An, Ö., Pendino, V., D’Antonio, M., Ratti, E., Gentilini, M., & Ciccarelli, F. D. (2014) · Database · doi:10.1093/database/bau015 · Cited by 63
Regulation of Toll-like Receptor Signaling by the SF3a mRNA Splicing Complex
O’Connor, B. P., Danhorn, T., Arras, L. D., Flatley, B. R., Marcus, R. A., Farias‐Hesson, E., Leach, S. M., & Alper, S. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004932 · Cited by 64
Myelodysplastic Syndromes
Germing, U., Kobbe, G., Haas, R. R., & Gattermann, N. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0783 · Cited by 67
SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes
Hanssens, K., Brenet, F. A., Agopian, J., Georgin‐Lavialle, S., Damaj, G. L., Cabaret, L., Chandesris, M., Sepulveda, P. D., Hermine, O., Dubreuil, P. C., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.095133 · Cited by 67
Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing
Shinde, M. Y., Sidoli, S., Kulej, K., Mallory, M. J., Radens, C. M., Reicherter, A. L., Myers, R. L., Barash, Y., Lynch, K. W., Garcia, B. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.813527 · Cited by 63
RNA-binding proteins in hematopoiesis and hematological malignancy
Hodson, D. J., Screen, M., & Turner, M. (2019) · Blood · doi:10.1182/blood-2018-10-839985 · Cited by 64
The Molecular Genetics of Myeloproliferative NeoplasmsPreprint
Marneth, A. E., & Mullally, A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034876 · Cited by 65
Polycomb complexes in normal and malignant hematopoiesis
Carlo, V. D., Mocavini, I., & Croce, L. D. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201808028 · Cited by 66
Long noncoding RNAs in biology and hematopoiesis
Paralkar, V. R., & Weiss, M. J. (2013) · Blood · doi:10.1182/blood-2013-03-456111 · Cited by 61
A Functional Screen Reveals an Extensive Layer of Transcriptional and Splicing Control Underlying RAS/MAPK Signaling in Drosophila
Ashton‐Beaucage, D., Udell, C. M., Gendron, P., Sahmi, M., Lefrançois, M., Baril, C., Guenier, A.-S., Duchaine, J., Lamarre, D., Lemieux, S., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001809 · Cited by 62
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
Zoi, K., & Cross, N. C. P. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1670-3 · Cited by 62
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
Togasaki, E., Takeda, J., Yoshida, K., Shiozawa, Y., Takeuchi, M., Oshima, M., Saraya, A., Iwama, A., Yokote, K., Sakaida, E., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.36 · Cited by 61
Self-citation
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation
Carlson, S. M., Soulette, C. M., Yang, Z., Elias, J. E., Brooks, A. N., & Gozani, O. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784371 · Cited by 61
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
Cheruiyot, A., Li, S., Srivatsan, S. N., Ahmed, T., Chen, Y., Lemacon, D. S., Li, Y., Yang, Z., Wadugu, B. A., Warner, W. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4016 · Cited by 61

Authors: Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., Chalkidis, G., Suzuki, Y., Shiosaka, M., Kawahata, R., Yamaguchi, T., Otsu, M., Obara, N., Sakata-Yanagimoto, M., Ishiyama, K., Mori, H., Nolte, F., Hofmann, W.-K., Miyawaki, S., Sugano, S., Haferlach, C., Koeffler, H. P., Shih, L.-Y., Haferlach, T., Chiba, S., Nakauchi, H., Miyano, S., & Ogawa, S.
Affiliations: The University of Tokyo (JP)
Institute of Medical Science, The University of Tokyo (JP)
Heidelberg University (DE)
Japan Science and Technology Agency (JP)
University of Tsukuba (JP)
Tokyo Metropolitan Ohtsuka Hospital (JP)
SHOWA Medical University Fujigaoka Hospital (JP)
Munich Leukemia Laboratory (Germany) (DE)
Cedars-Sinai Medical Center (US)
Chang Gung University (TW)
Corresponding author: Ogawa, Seishi
ORCID: Yoshida, Kenichi
Sanada, Masashi
Shiraishi, Yuichi
Nowak, Daniel
Nagata, Yasunobu
Sato, Yusuke
Kon, Ayana
Nagasaki, Masao
Suzuki, Yutaka
Yamaguchi, Tomoyuki
Otsu, Makoto
Obara, Naoshi
Ishiyama, Ken
Nolte, Florian
Miyawaki, Shuichi
Sugano, Sumio
Haferlach, Claudia
Koeffler, H. Phillip
Shih, Lee-Yung
Haferlach, Torsten
Chiba, Shigeru
Nakauchi, Hiromitsu
Miyano, Satoru
Ogawa, Seishi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-09-11
Volume: 478
Issue: 7367
Pages: 64-69
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10496
OpenAlex: W2073889874
Cited by: 2,029
References: 37
Citations by year: 2026: 71 · 2025: 76 · 2024: 121 · 2023: 101 · 2022: 139 · 2021: 160 · 2020: 148 · 2019: 135 · 2018: 135 · 2017: 148 · 2016: 146 · 2015: 145 · 2014: 173 · 2013: 171 · 2012: 135
FWCI: 64.98
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Japan Society for the Promotion of Science (22390191, 23791075, 22790895, 23659533, 23659482, 23390269, 23791068, 22659058)
National Cancer Institute (R01CA026038)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: myelodysplastic syndrome, splicing mutation, U2AF35, ZRSR2, SRSF2, SF3B1, 3' splice site recognition, pre-mRNA splicing, hematopoiesis, acute myeloid leukemia, myeloid neoplasms, aberrant splicing, therapeutic target
MeSH terms: Splicing Factor U2AF, Hematopoiesis, Humans, Mutation, Myelodysplastic Syndromes, Nuclear Proteins, Ribonucleoproteins, RNA Splicing, Spliceosomes, Alternative Splicing, Polymorphism, Single Nucleotide, RNA Splice Sites, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent pathway mutations of splicing machinery in myelodysplasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks